AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39026331|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|39026331|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39142019|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|29|38424803|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|39026331|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|82|39142019|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.2|0.2|Malignant|74|38424803|Female|Astrocytoma, NOS|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39026331|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39026331|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39142019|Female|Choroid plexus|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39142019|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|38424803|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|38424803|Female|Choroid plexus|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|39026331|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39026331|Female|Craniopharyngioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|39142019|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39142019|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|38424803|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|38424803|Female|Craniopharyngioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|39026331|Female|Diffuse astrocytoma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|39142019|Female|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|209|39026331|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|182|39142019|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|195|38424803|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|39026331|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|101|39142019|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|38424803|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39026331|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|44|39142019|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Germ Cell Tumors|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|38424803|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39026331|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39142019|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|38424803|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|211|39026331|Female|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|205|39142019|Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.5|Malignant|201|38424803|Female|Glioma malignant, NOS|2006|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39142019|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39142019|Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|38424803|Female|Hemangioma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|38424803|Female|Hemangioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|44|39026331|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39026331|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|39142019|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39142019|Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|38424803|Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|38424803|Female|Meningioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|39026331|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39142019|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Mixed glioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|39026331|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|39026331|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|47|39142019|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|39142019|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|42|38424803|Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|38424803|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|94|39026331|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39026331|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|39142019|Female|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39142019|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|38424803|Female|Nerve sheath, benign and malignant|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38424803|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Neuroepithelial|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|108|39026331|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|39026331|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|128|39142019|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|39142019|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|105|38424803|Female|Neuronal/glial, neuronal|2006|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|38424803|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|39026331|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39142019|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|38424803|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Other mesenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Other mesenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|309|39026331|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|306|39142019|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.8|0.7|Malignant|282|38424803|Female|Pilocytic astrocytoma|2006|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39026331|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39026331|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39142019|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39142019|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|38424803|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|38424803|Female|Pineal parenchymal|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|210|39026331|Female|Pituitary|2004|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|39026331|Female|Pituitary|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|204|39142019|Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|39142019|Female|Pituitary|2005|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|227|38424803|Female|Pituitary|2006|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|38424803|Female|Pituitary|2006|~|~|~
0-19|1.6|1.9|1.8|Benign/Borderline|689|39026331|Female|Total|2004|1.6|1.9|1.8
0-19|3.0|3.3|3.1|Malignant|1225|39026331|Female|Total|2004|3.0|3.3|3.1
0-19|1.7|2.0|1.9|Benign/Borderline|737|39142019|Female|Total|2005|1.7|2.0|1.9
0-19|2.8|3.1|3.0|Malignant|1155|39142019|Female|Total|2005|2.8|3.1|3.0
0-19|1.6|1.9|1.8|Benign/Borderline|686|38424803|Female|Total|2006|1.7|1.9|1.8
0-19|2.7|3.0|2.8|Malignant|1086|38424803|Female|Total|2006|2.7|3.0|2.8
0-19|0.2|0.3|0.2|Benign/Borderline|94|39026331|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39026331|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|39142019|Female|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39142019|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|38424803|Female|Tumors of Cranial and Spinal Nerves|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|38424803|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|178|39026331|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.7|3.1|2.9|Malignant|1132|39026331|Female|Tumors of Neuroepthelial Tissue|2004|2.7|3.1|2.9
0-19|0.4|0.5|0.5|Benign/Borderline|179|39142019|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
0-19|2.6|2.9|2.7|Malignant|1068|39142019|Female|Tumors of Neuroepthelial Tissue|2005|2.6|2.9|2.7
0-19|0.4|0.5|0.4|Benign/Borderline|171|38424803|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
0-19|2.5|2.8|2.7|Malignant|1024|38424803|Female|Tumors of Neuroepthelial Tissue|2006|2.5|2.8|2.7
0-19|0.7|0.8|0.7|Benign/Borderline|291|39026331|Female|Tumors of Sellar Region|2004|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|39026331|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|275|39142019|Female|Tumors of Sellar Region|2005|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39142019|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|296|38424803|Female|Tumors of Sellar Region|2006|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|38424803|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|39026331|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39026331|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|39142019|Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39142019|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|38424803|Female|Tumors of the Meninges|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|38424803|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39026331|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|39026331|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|68|39142019|Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|39142019|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|59|38424803|Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|38424803|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|39026331|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|39026331|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|17|39142019|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|39142019|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|18|38424803|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|18|38424803|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40953126|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40953126|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|41058994|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40293824|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40953126|Male|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|41058994|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40293824|Male|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|25|40953126|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40953126|Male|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41058994|Male|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41058994|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40293824|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40293824|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40953126|Male|Craniopharyngioma|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40953126|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|41058994|Male|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41058994|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40293824|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40293824|Male|Craniopharyngioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40953126|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|41058994|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40293824|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|282|40953126|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.7|0.6|Malignant|264|41058994|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|270|40293824|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41058994|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41058994|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40293824|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40293824|Male|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|40953126|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|41058994|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|105|40293824|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|17|40953126|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|104|40953126|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|16|41058994|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|81|41058994|Male|Germ Cell Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|40293824|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|86|40293824|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|70|40953126|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|41058994|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|40293824|Male|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|40953126|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|41058994|Male|Glioma malignant, NOS|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|197|40293824|Male|Glioma malignant, NOS|2006|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|17|40953126|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40953126|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40953126|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40953126|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41058994|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41058994|Male|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40293824|Male|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40293824|Male|Hemangioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40953126|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40953126|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|41058994|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41058994|Male|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|40293824|Male|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40293824|Male|Meningioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Mixed glioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40953126|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40953126|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|49|41058994|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|22|41058994|Male|Neoplasm, unspecified|2005|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|40293824|Male|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|40293824|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|110|40953126|Male|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40953126|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41058994|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41058994|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|98|40293824|Male|Nerve sheath, benign and malignant|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40293824|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Neuroepithelial|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|40953126|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40953126|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|144|41058994|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|41058994|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40293824|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|30|40293824|Male|Neuronal/glial, neuronal|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|40953126|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|41058994|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40293824|Male|Oligodendroglioma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|40953126|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41058994|Male|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41058994|Male|Other mesenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|349|40953126|Male|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|327|41058994|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|327|40293824|Male|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40953126|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40953126|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41058994|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|41058994|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40293824|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40293824|Male|Pineal parenchymal|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40953126|Male|Pituitary|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40953126|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|100|41058994|Male|Pituitary|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41058994|Male|Pituitary|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|40293824|Male|Pituitary|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40293824|Male|Pituitary|2006|~|~|~
0-19|1.4|1.6|1.5|Benign/Borderline|621|40953126|Male|Total|2004|1.4|1.6|1.5
0-19|3.3|3.7|3.5|Malignant|1425|40953126|Male|Total|2004|3.3|3.7|3.5
0-19|1.5|1.7|1.6|Benign/Borderline|654|41058994|Male|Total|2005|1.5|1.7|1.6
0-19|3.1|3.4|3.3|Malignant|1338|41058994|Male|Total|2005|3.1|3.4|3.3
0-19|1.4|1.6|1.5|Benign/Borderline|614|40293824|Male|Total|2006|1.4|1.6|1.5
0-19|3.2|3.5|3.3|Malignant|1346|40293824|Male|Total|2006|3.2|3.5|3.3
0-19|0.2|0.3|0.3|Benign/Borderline|110|40953126|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40953126|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41058994|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41058994|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|98|40293824|Male|Tumors of Cranial and Spinal Nerves|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40293824|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|207|40953126|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.6|0.5
0-19|3.0|3.3|3.1|Malignant|1285|40953126|Male|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|229|41058994|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.8|3.1|2.9|Malignant|1209|41058994|Male|Tumors of Neuroepthelial Tissue|2005|2.8|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|226|40293824|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|2.8|3.2|3.0|Malignant|1211|40293824|Male|Tumors of Neuroepthelial Tissue|2006|2.8|3.2|3.0
0-19|0.3|0.4|0.4|Benign/Borderline|152|40953126|Male|Tumors of Sellar Region|2004|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40953126|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|41058994|Male|Tumors of Sellar Region|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41058994|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|40293824|Male|Tumors of Sellar Region|2006|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40293824|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40953126|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40953126|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|41058994|Male|Tumors of the Meninges|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41058994|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40293824|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40293824|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40953126|Male|Unclassified Tumors|2004|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|40953126|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|66|41058994|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|41058994|Male|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|61|40293824|Male|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|27|40293824|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|25|40953126|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40953126|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41058994|Male|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41058994|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40293824|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|19|40293824|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|79979457|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|80201013|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|78718627|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|79979457|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|55|80201013|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|60|78718627|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|79979457|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|80201013|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|78718627|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|179|79979457|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|176|80201013|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.2|0.2|Malignant|166|78718627|Male and Female|Astrocytoma, NOS|2006|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|54|79979457|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|79979457|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|49|80201013|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|80201013|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|78718627|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|78718627|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|157|79979457|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|79979457|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|152|80201013|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|80201013|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|135|78718627|Male and Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|78718627|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|40|79979457|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|80201013|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|78718627|Male and Female|Diffuse astrocytoma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|491|79979457|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|446|80201013|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|465|78718627|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|24|79979457|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|79979457|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|80201013|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|80201013|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|78718627|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78718627|Male and Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|79979457|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|202|80201013|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|78718627|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|29|79979457|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|146|79979457|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|30|80201013|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|125|80201013|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|78718627|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|109|78718627|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|123|79979457|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|80201013|Male and Female|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|98|78718627|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|427|79979457|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|401|80201013|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.5|Malignant|398|78718627|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|28|79979457|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|79979457|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|80201013|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|80201013|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|16|78718627|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|78718627|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|79979457|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|79979457|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|80201013|Male and Female|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|80201013|Male and Female|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|40|78718627|Male and Female|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|78718627|Male and Female|Hemangioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|79979457|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|80201013|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|78718627|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|79979457|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|80201013|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|78718627|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|85|79979457|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|79979457|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|111|80201013|Male and Female|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|80201013|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|79|78718627|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|78718627|Male and Female|Meningioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|79979457|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|80201013|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|78718627|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|75|79979457|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|79979457|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|96|80201013|Male and Female|Neoplasm, unspecified|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|80201013|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|80|78718627|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|78718627|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|204|79979457|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|79979457|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|201|80201013|Male and Female|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|80201013|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|192|78718627|Male and Female|Nerve sheath, benign and malignant|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|78718627|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|79979457|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|80201013|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|78718627|Male and Female|Neuroepithelial|2006|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|247|79979457|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|47|79979457|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|272|80201013|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|80201013|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|242|78718627|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|51|78718627|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|57|79979457|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|80201013|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|78718627|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|25|79979457|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|79979457|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|80201013|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|80201013|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|28|78718627|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|78718627|Male and Female|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.8|Malignant|658|79979457|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|633|80201013|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.8|0.8|Malignant|609|78718627|Male and Female|Pilocytic astrocytoma|2006|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|79979457|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|79979457|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|80201013|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|80201013|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|78718627|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|78718627|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|286|79979457|Male and Female|Pituitary|2004|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|79979457|Male and Female|Pituitary|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|304|80201013|Male and Female|Pituitary|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|80201013|Male and Female|Pituitary|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|299|78718627|Male and Female|Pituitary|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|78718627|Male and Female|Pituitary|2006|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|1310|79979457|Male and Female|Total|2004|1.6|1.7|1.6
0-19|3.2|3.4|3.3|Malignant|2650|79979457|Male and Female|Total|2004|3.2|3.4|3.3
0-19|1.6|1.8|1.7|Benign/Borderline|1391|80201013|Male and Female|Total|2005|1.6|1.8|1.7
0-19|3.0|3.2|3.1|Malignant|2493|80201013|Male and Female|Total|2005|3.0|3.2|3.1
0-19|1.6|1.7|1.6|Benign/Borderline|1300|78718627|Male and Female|Total|2006|1.6|1.7|1.7
0-19|3.0|3.2|3.1|Malignant|2432|78718627|Male and Female|Total|2006|3.0|3.2|3.1
0-19|0.2|0.3|0.3|Benign/Borderline|204|79979457|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|79979457|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|201|80201013|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|80201013|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|192|78718627|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|78718627|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|385|79979457|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.1|3.0|Malignant|2417|79979457|Male and Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.1|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|408|80201013|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.7|3.0|2.8|Malignant|2277|80201013|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.8
0-19|0.5|0.6|0.5|Benign/Borderline|397|78718627|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
0-19|2.7|3.0|2.8|Malignant|2235|78718627|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.8
0-19|0.5|0.6|0.6|Benign/Borderline|443|79979457|Male and Female|Tumors of Sellar Region|2004|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|79979457|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|456|80201013|Male and Female|Tumors of Sellar Region|2005|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|80201013|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|434|78718627|Male and Female|Tumors of Sellar Region|2006|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|78718627|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|138|79979457|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|79979457|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|162|80201013|Male and Female|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|80201013|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|123|78718627|Male and Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|78718627|Male and Female|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|79979457|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|42|79979457|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|134|80201013|Male and Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|80201013|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|120|78718627|Male and Female|Unclassified Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|78718627|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|42|79979457|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|79979457|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|47|80201013|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|28|80201013|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|35|78718627|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|37|78718627|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|107164105|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|107164105|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|108316266|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108316266|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|107285283|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107285283|Female|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|107164105|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|536|107164105|Female|Anaplastic astrocytoma|2004|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|108316266|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|480|108316266|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|107285283|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|464|107285283|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|107164105|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|174|107164105|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108316266|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|153|108316266|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|107285283|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|123|107285283|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|107164105|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.5|0.5|Malignant|547|107164105|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|108316266|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|532|108316266|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|107285283|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|476|107285283|Female|Astrocytoma, NOS|2006|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|107164105|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107164105|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108316266|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108316266|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|41|107285283|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|107285283|Female|Choroid plexus|2006|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|181|107164105|Female|Craniopharyngioma|2004|0.1|0.2|0.2
20+|~|~|~|Malignant|~|107164105|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|166|108316266|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|108316266|Female|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|172|107285283|Female|Craniopharyngioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|107285283|Female|Craniopharyngioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|107164105|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|109|107164105|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108316266|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|123|108316266|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|107285283|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|85|107285283|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|107164105|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.0|0.1|0.1|Malignant|66|107164105|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108316266|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|80|108316266|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|107285283|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.0|0.1|0.1|Malignant|67|107285283|Female|Embryonal/primitive/medulloblastoma|2006|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|100|107164105|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|107164105|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|106|108316266|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|108316266|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|132|107285283|Female|Ependymoma variants|2006|0.1|0.1|0.1
20+|~|~|~|Malignant|~|107285283|Female|Ependymoma variants|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|107164105|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|273|107164105|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108316266|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|288|108316266|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|107285283|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|267|107285283|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|18|107164105|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107164105|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108316266|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108316266|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|107285283|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107285283|Female|Germ Cell Tumors|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|107164105|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|3977|107164105|Female|Glioblastoma|2004|3.6|3.8|3.7
20+|~|~|~|Benign/Borderline|~|108316266|Female|Glioblastoma|2005|~|~|~
20+|3.3|3.6|3.5|Malignant|4025|108316266|Female|Glioblastoma|2005|3.6|3.8|3.7
20+|~|~|~|Benign/Borderline|~|107285283|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.6|3.5|Malignant|4026|107285283|Female|Glioblastoma|2006|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|107164105|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|403|107164105|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108316266|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|377|108316266|Female|Glioma malignant, NOS|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|107285283|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|363|107285283|Female|Glioma malignant, NOS|2006|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|201|107164105|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|107164105|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|211|108316266|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108316266|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|195|107285283|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|107285283|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|205|107164105|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|107164105|Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|108316266|Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108316266|Female|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|219|107285283|Female|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|107285283|Female|Hemangioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|107164105|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|107164105|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108316266|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107285283|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|17|107285283|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107164105|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.5|0.5|Malignant|572|107164105|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|108316266|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|636|108316266|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|107285283|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|615|107285283|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.5|0.6|0.6
20+|11.0|11.4|11.2|Benign/Borderline|12797|107164105|Female|Meningioma|2004|11.7|12.2|11.9
20+|0.2|0.3|0.2|Malignant|278|107164105|Female|Meningioma|2004|0.2|0.3|0.3
20+|11.6|12.0|11.8|Benign/Borderline|13719|108316266|Female|Meningioma|2005|12.5|12.9|12.7
20+|0.2|0.3|0.2|Malignant|258|108316266|Female|Meningioma|2005|0.2|0.3|0.2
20+|11.6|12.0|11.8|Benign/Borderline|13687|107285283|Female|Meningioma|2006|12.5|13.0|12.8
20+|0.2|0.2|0.2|Malignant|238|107285283|Female|Meningioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|107164105|Female|Mixed glioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|181|107164105|Female|Mixed glioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108316266|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|213|108316266|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|107285283|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|250|107285283|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|0.6|0.7|0.6|Benign/Borderline|728|107164105|Female|Neoplasm, unspecified|2004|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|676|107164105|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|763|108316266|Female|Neoplasm, unspecified|2005|0.7|0.8|0.7
20+|0.5|0.6|0.5|Malignant|662|108316266|Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.6|0.6|Benign/Borderline|704|107285283|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|645|107285283|Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|2.1|2.3|2.2|Benign/Borderline|2410|107164105|Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|19|107164105|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2415|108316266|Female|Nerve sheath, benign and malignant|2005|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2359|107285283|Female|Nerve sheath, benign and malignant|2006|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|23|107285283|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107164105|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|18|107164105|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108316266|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107285283|Female|Neuroepithelial|2006|~|~|~
20+|~|~|~|Malignant|~|107285283|Female|Neuroepithelial|2006|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|140|107164105|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|107164105|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|170|108316266|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|173|107285283|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|107285283|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107164105|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|325|107164105|Female|Oligodendroglioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108316266|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|321|108316266|Female|Oligodendroglioma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|107285283|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|337|107285283|Female|Oligodendroglioma|2006|0.3|0.3|0.3
20+|0.0|0.1|0.1|Benign/Borderline|67|107164105|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|107164105|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|71|108316266|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|108316266|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|71|107285283|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|107285283|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|107164105|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|115|107164105|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108316266|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|143|108316266|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|107285283|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|136|107285283|Female|Pilocytic astrocytoma|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|107164105|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|107164105|Female|Pineal parenchymal|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|108316266|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108316266|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|107285283|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|107285283|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|3.0|3.2|3.1|Benign/Borderline|3331|107164105|Female|Pituitary|2004|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|21|107164105|Female|Pituitary|2004|0.0|0.0|0.0
20+|3.3|3.5|3.4|Benign/Borderline|3640|108316266|Female|Pituitary|2005|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Pituitary|2005|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3771|107285283|Female|Pituitary|2006|3.4|3.6|3.5
20+|~|~|~|Malignant|~|107285283|Female|Pituitary|2006|~|~|~
20+|17.8|18.3|18.1|Benign/Borderline|20295|107164105|Female|Total|2004|18.7|19.2|18.9
20+|7.3|7.6|7.5|Malignant|8409|107164105|Female|Total|2004|7.7|8.0|7.8
20+|18.7|19.2|19.0|Benign/Borderline|21629|108316266|Female|Total|2005|19.7|20.2|20.0
20+|7.2|7.6|7.4|Malignant|8477|108316266|Female|Total|2005|7.7|8.0|7.8
20+|18.8|19.3|19.1|Benign/Borderline|21633|107285283|Female|Total|2006|19.9|20.4|20.2
20+|7.1|7.4|7.3|Malignant|8268|107285283|Female|Total|2006|7.5|7.9|7.7
20+|2.1|2.3|2.2|Benign/Borderline|2410|107164105|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|19|107164105|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.1|2.3|2.2|Benign/Borderline|2417|108316266|Female|Tumors of Cranial and Spinal Nerves|2005|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2359|107285283|Female|Tumors of Cranial and Spinal Nerves|2006|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|23|107285283|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|353|107164105|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|5.9|6.2|6.1|Malignant|6774|107164105|Female|Tumors of Neuroepthelial Tissue|2004|6.2|6.5|6.3
20+|0.3|0.4|0.4|Benign/Borderline|385|108316266|Female|Tumors of Neuroepthelial Tissue|2005|0.3|0.4|0.4
20+|5.9|6.2|6.0|Malignant|6818|108316266|Female|Tumors of Neuroepthelial Tissue|2005|6.1|6.4|6.3
20+|0.4|0.4|0.4|Benign/Borderline|422|107285283|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.4|0.4
20+|5.8|6.1|5.9|Malignant|6679|107285283|Female|Tumors of Neuroepthelial Tissue|2006|6.1|6.4|6.2
20+|3.2|3.4|3.3|Benign/Borderline|3512|107164105|Female|Tumors of Sellar Region|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|21|107164105|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3806|108316266|Female|Tumors of Sellar Region|2005|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|21|108316266|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|3943|107285283|Female|Tumors of Sellar Region|2006|3.6|3.8|3.7
20+|~|~|~|Malignant|~|107285283|Female|Tumors of Sellar Region|2006|~|~|~
20+|11.2|11.6|11.4|Benign/Borderline|13065|107164105|Female|Tumors of the Meninges|2004|12.0|12.4|12.2
20+|0.2|0.3|0.3|Malignant|304|107164105|Female|Tumors of the Meninges|2004|0.3|0.3|0.3
20+|11.8|12.2|12.0|Benign/Borderline|14001|108316266|Female|Tumors of the Meninges|2005|12.7|13.1|12.9
20+|0.2|0.3|0.2|Malignant|285|108316266|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|11.8|12.2|12.0|Benign/Borderline|13953|107285283|Female|Tumors of the Meninges|2006|12.8|13.2|13.0
20+|0.2|0.3|0.2|Malignant|264|107285283|Female|Tumors of the Meninges|2006|0.2|0.3|0.2
20+|0.8|0.9|0.8|Benign/Borderline|936|107164105|Female|Unclassified Tumors|2004|0.8|0.9|0.9
20+|0.5|0.6|0.6|Malignant|683|107164105|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|990|108316266|Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.5|0.6|0.5|Malignant|667|108316266|Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|930|107285283|Female|Unclassified Tumors|2006|0.8|0.9|0.9
20+|0.5|0.6|0.5|Malignant|648|107285283|Female|Unclassified Tumors|2006|0.6|0.7|0.6
20+|0.0|0.1|0.0|Benign/Borderline|47|107164105|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|107164105|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|108316266|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|108316266|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|107285283|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|107285283|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|100537750|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|101838145|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|101838145|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|101012560|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101012560|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|100537750|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|639|100537750|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|101838145|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|629|101838145|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|101012560|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|628|101012560|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|100537750|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|192|100537750|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101838145|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|183|101838145|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101012560|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|198|101012560|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|100537750|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|605|100537750|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|101838145|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|609|101838145|Male|Astrocytoma, NOS|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|101012560|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|579|101012560|Male|Astrocytoma, NOS|2006|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|20|100537750|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|100537750|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|101838145|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101838145|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|101012560|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101012560|Male|Choroid plexus|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|179|100537750|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|100537750|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|209|101838145|Male|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101838145|Male|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|101012560|Male|Craniopharyngioma|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101012560|Male|Craniopharyngioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|100537750|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|128|100537750|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101838145|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|144|101838145|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101012560|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|184|101012560|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|100537750|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|92|100537750|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101838145|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|100|101838145|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101012560|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|86|101012560|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|139|100537750|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|100537750|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|135|101838145|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101838145|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|139|101012560|Male|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101012560|Male|Ependymoma variants|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|100537750|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|278|100537750|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|101838145|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|282|101838145|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|101012560|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|249|101012560|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|23|100537750|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|41|100537750|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|101838145|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|48|101838145|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|101012560|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101012560|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5355|100537750|Male|Glioblastoma|2004|5.2|5.5|5.3
20+|~|~|~|Benign/Borderline|~|101838145|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.5|Malignant|5334|101838145|Male|Glioblastoma|2005|5.1|5.4|5.2
20+|~|~|~|Benign/Borderline|~|101012560|Male|Glioblastoma|2006|~|~|~
20+|5.2|5.5|5.3|Malignant|5158|101012560|Male|Glioblastoma|2006|5.0|5.2|5.1
20+|~|~|~|Benign/Borderline|~|100537750|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|408|100537750|Male|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|101838145|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|434|101838145|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|101012560|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|393|101012560|Male|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|0.2|0.3|0.2|Benign/Borderline|236|100537750|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|100537750|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|251|101838145|Male|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101838145|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|244|101012560|Male|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101012560|Male|Hemangioblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|100537750|Male|Hemangioma|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|100537750|Male|Hemangioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|154|101838145|Male|Hemangioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|101838145|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|175|101012560|Male|Hemangioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|101012560|Male|Hemangioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|100537750|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|23|100537750|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101838145|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|27|101838145|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101012560|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|32|101012560|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.7|Malignant|702|100537750|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.8|0.7
20+|~|~|~|Benign/Borderline|~|101838145|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|737|101838145|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|101012560|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.7|Malignant|692|101012560|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|4.8|5.1|4.9|Benign/Borderline|4533|100537750|Male|Meningioma|2004|4.4|4.6|4.5
20+|0.2|0.2|0.2|Malignant|169|100537750|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.0|5.3|5.1|Benign/Borderline|4779|101838145|Male|Meningioma|2005|4.6|4.8|4.7
20+|0.1|0.2|0.2|Malignant|155|101838145|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.0|5.3|5.1|Benign/Borderline|4808|101012560|Male|Meningioma|2006|4.6|4.9|4.8
20+|0.1|0.2|0.1|Malignant|133|101012560|Male|Meningioma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|100537750|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|268|100537750|Male|Mixed glioma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|101838145|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|304|101838145|Male|Mixed glioma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|101012560|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|327|101012560|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|0.5|0.6|0.6|Benign/Borderline|523|100537750|Male|Neoplasm, unspecified|2004|0.5|0.6|0.5
20+|0.6|0.7|0.7|Malignant|598|100537750|Male|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|573|101838145|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|558|101838145|Male|Neoplasm, unspecified|2005|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|530|101012560|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|528|101012560|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2175|100537750|Male|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|100537750|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2334|101838145|Male|Nerve sheath, benign and malignant|2005|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|29|101838145|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2160|101012560|Male|Nerve sheath, benign and malignant|2006|2.0|2.2|2.1
20+|0.0|0.0|0.0|Malignant|18|101012560|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|27|100537750|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101838145|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|101838145|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101012560|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|21|101012560|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|155|100537750|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|100537750|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|171|101838145|Male|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|101838145|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|167|101012560|Male|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|101012560|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|440|100537750|Male|Oligodendroglioma|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|101838145|Male|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|395|101838145|Male|Oligodendroglioma|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|101012560|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|400|101012560|Male|Oligodendroglioma|2006|0.4|0.4|0.4
20+|0.1|0.1|0.1|Benign/Borderline|78|100537750|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|21|100537750|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|63|101838145|Male|Other mesenchymal|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|101838145|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|63|101012560|Male|Other mesenchymal|2006|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|101012560|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|100537750|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|141|100537750|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101838145|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|149|101838145|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101012560|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|139|101012560|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|100537750|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|100537750|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|101838145|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|17|101838145|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101012560|Male|Pineal parenchymal|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|17|101012560|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|2940|100537750|Male|Pituitary|2004|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|100537750|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.0|3.2|3.1|Benign/Borderline|3062|101838145|Male|Pituitary|2005|2.9|3.1|3.0
20+|~|~|~|Malignant|~|101838145|Male|Pituitary|2005|~|~|~
20+|3.1|3.3|3.2|Benign/Borderline|3168|101012560|Male|Pituitary|2006|3.0|3.2|3.1
20+|~|~|~|Malignant|~|101012560|Male|Pituitary|2006|~|~|~
20+|11.6|12.0|11.8|Benign/Borderline|11243|100537750|Male|Total|2004|11.0|11.4|11.2
20+|10.5|10.9|10.7|Malignant|10238|100537750|Male|Total|2004|10.0|10.4|10.2
20+|12.1|12.5|12.3|Benign/Borderline|11923|101838145|Male|Total|2005|11.5|11.9|11.7
20+|10.4|10.8|10.6|Malignant|10260|101838145|Male|Total|2005|9.9|10.3|10.1
20+|11.9|12.4|12.2|Benign/Borderline|11791|101012560|Male|Total|2006|11.5|11.9|11.7
20+|10.0|10.4|10.2|Malignant|9923|101012560|Male|Total|2006|9.6|10.0|9.8
20+|2.1|2.3|2.2|Benign/Borderline|2175|100537750|Male|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|100537750|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2334|101838145|Male|Tumors of Cranial and Spinal Nerves|2005|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|29|101838145|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.0|2.2|2.1|Benign/Borderline|2161|101012560|Male|Tumors of Cranial and Spinal Nerves|2006|2.1|2.2|2.1
20+|0.0|0.0|0.0|Malignant|18|101012560|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|430|100537750|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.7|9.1|8.9|Malignant|8630|100537750|Male|Tumors of Neuroepthelial Tissue|2004|8.4|8.8|8.6
20+|0.4|0.5|0.5|Benign/Borderline|472|101838145|Male|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|8.7|9.0|8.8|Malignant|8651|101838145|Male|Tumors of Neuroepthelial Tissue|2005|8.3|8.7|8.5
20+|0.4|0.5|0.5|Benign/Borderline|466|101012560|Male|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|8.4|8.8|8.6|Malignant|8430|101012560|Male|Tumors of Neuroepthelial Tissue|2006|8.2|8.5|8.3
20+|3.1|3.3|3.2|Benign/Borderline|3119|100537750|Male|Tumors of Sellar Region|2004|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|21|100537750|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|3271|101838145|Male|Tumors of Sellar Region|2005|3.1|3.3|3.2
20+|~|~|~|Malignant|~|101838145|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.3|3.5|3.4|Benign/Borderline|3319|101012560|Male|Tumors of Sellar Region|2006|3.2|3.4|3.3
20+|~|~|~|Malignant|~|101012560|Male|Tumors of Sellar Region|2006|~|~|~
20+|5.1|5.4|5.2|Benign/Borderline|4847|100537750|Male|Tumors of the Meninges|2004|4.7|5.0|4.8
20+|0.2|0.2|0.2|Malignant|190|100537750|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.3|5.6|5.4|Benign/Borderline|5093|101838145|Male|Tumors of the Meninges|2005|4.9|5.1|5.0
20+|0.2|0.2|0.2|Malignant|189|101838145|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|5.3|5.6|5.4|Benign/Borderline|5115|101012560|Male|Tumors of the Meninges|2006|4.9|5.2|5.1
20+|0.1|0.2|0.2|Malignant|161|101012560|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|647|100537750|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|605|100537750|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.7|0.8|0.8|Benign/Borderline|728|101838145|Male|Unclassified Tumors|2005|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|566|101838145|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.7|0.8|0.7|Benign/Borderline|706|101012560|Male|Unclassified Tumors|2006|0.6|0.8|0.7
20+|0.5|0.7|0.6|Malignant|536|101012560|Male|Unclassified Tumors|2006|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|96|100537750|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|100537750|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|106|101838145|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101838145|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|114|101012560|Male|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|101012560|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|207701855|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|207701855|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|210154411|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|210154411|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|208297843|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|208297843|Male and Female|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1175|207701855|Male and Female|Anaplastic astrocytoma|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.5|Malignant|1109|210154411|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1092|208297843|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|366|207701855|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.2|Malignant|336|210154411|Male and Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|321|208297843|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1152|207701855|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.5|Malignant|1141|210154411|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.5|0.5|Malignant|1055|208297843|Male and Female|Astrocytoma, NOS|2006|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|58|207701855|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|207701855|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|58|210154411|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|210154411|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|62|208297843|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|208297843|Male and Female|Choroid plexus|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|360|207701855|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|207701855|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|375|210154411|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|210154411|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|323|208297843|Male and Female|Craniopharyngioma|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|208297843|Male and Female|Craniopharyngioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|237|207701855|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|267|210154411|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|269|208297843|Male and Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|158|207701855|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|180|210154411|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|153|208297843|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|239|207701855|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|207701855|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|241|210154411|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|210154411|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|271|208297843|Male and Female|Ependymoma variants|2006|0.1|0.1|0.1
20+|~|~|~|Malignant|~|208297843|Male and Female|Ependymoma variants|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|551|207701855|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|570|210154411|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|516|208297843|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|41|207701855|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|207701855|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|210154411|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|210154411|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|208297843|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|208297843|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.5|4.5|Malignant|9332|207701855|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Glioblastoma|2005|~|~|~
20+|4.3|4.5|4.4|Malignant|9359|210154411|Male and Female|Glioblastoma|2005|4.4|4.5|4.5
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Glioblastoma|2006|~|~|~
20+|4.2|4.4|4.3|Malignant|9184|208297843|Male and Female|Glioblastoma|2006|4.3|4.5|4.4
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|811|207701855|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|811|210154411|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|756|208297843|Male and Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|437|207701855|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|207701855|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|462|210154411|Male and Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|210154411|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|439|208297843|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|208297843|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|327|207701855|Male and Female|Hemangioma|2004|0.1|0.2|0.2
20+|~|~|~|Malignant|~|207701855|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|378|210154411|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|210154411|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|394|208297843|Male and Female|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|208297843|Male and Female|Hemangioma|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|47|207701855|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|48|210154411|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|49|208297843|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1274|207701855|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1373|210154411|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|1307|208297843|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|8.2|8.4|8.3|Benign/Borderline|17330|207701855|Male and Female|Meningioma|2004|8.2|8.5|8.3
20+|0.2|0.2|0.2|Malignant|447|207701855|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|8.6|8.8|8.7|Benign/Borderline|18498|210154411|Male and Female|Meningioma|2005|8.7|8.9|8.8
20+|0.2|0.2|0.2|Malignant|413|210154411|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|8.6|8.9|8.7|Benign/Borderline|18495|208297843|Male and Female|Meningioma|2006|8.8|9.0|8.9
20+|0.2|0.2|0.2|Malignant|371|208297843|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|449|207701855|Male and Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|517|210154411|Male and Female|Mixed glioma|2005|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|577|208297843|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|0.6|0.6|0.6|Benign/Borderline|1251|207701855|Male and Female|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.6|0.6|Malignant|1274|207701855|Male and Female|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1336|210154411|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|1220|210154411|Male and Female|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1234|208297843|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.5|0.6|0.5|Malignant|1173|208297843|Male and Female|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|2.1|2.2|2.2|Benign/Borderline|4585|207701855|Male and Female|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|45|207701855|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.2|2.3|2.2|Benign/Borderline|4749|210154411|Male and Female|Nerve sheath, benign and malignant|2005|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|50|210154411|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.1|2.2|2.1|Benign/Borderline|4519|208297843|Male and Female|Nerve sheath, benign and malignant|2006|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|41|208297843|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|45|207701855|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|39|210154411|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|36|208297843|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|295|207701855|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|34|207701855|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|341|210154411|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|52|210154411|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|340|208297843|Male and Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|208297843|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|765|207701855|Male and Female|Oligodendroglioma|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|716|210154411|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|737|208297843|Male and Female|Oligodendroglioma|2006|0.3|0.4|0.4
20+|0.1|0.1|0.1|Benign/Borderline|145|207701855|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|47|207701855|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|134|210154411|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|210154411|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|134|208297843|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|208297843|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|207701855|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|256|207701855|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|210154411|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|292|210154411|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|208297843|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|275|208297843|Male and Female|Pilocytic astrocytoma|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|207701855|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|207701855|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|210154411|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|210154411|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|208297843|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|38|208297843|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|6271|207701855|Male and Female|Pituitary|2004|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|42|207701855|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.1|3.3|3.2|Benign/Borderline|6702|210154411|Male and Female|Pituitary|2005|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|33|210154411|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|6939|208297843|Male and Female|Pituitary|2006|3.3|3.4|3.3
20+|0.0|0.0|0.0|Malignant|19|208297843|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|14.9|15.3|15.1|Benign/Borderline|31538|207701855|Male and Female|Total|2004|15.0|15.4|15.2
20+|8.8|9.1|8.9|Malignant|18647|207701855|Male and Female|Total|2004|8.8|9.1|9.0
20+|15.7|16.0|15.8|Benign/Borderline|33552|210154411|Male and Female|Total|2005|15.8|16.1|16.0
20+|8.7|9.0|8.8|Malignant|18737|210154411|Male and Female|Total|2005|8.8|9.0|8.9
20+|15.7|16.0|15.8|Benign/Borderline|33424|208297843|Male and Female|Total|2006|15.9|16.2|16.0
20+|8.5|8.8|8.6|Malignant|18191|208297843|Male and Female|Total|2006|8.6|8.9|8.7
20+|2.1|2.2|2.2|Benign/Borderline|4585|207701855|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|45|207701855|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.2|2.3|2.2|Benign/Borderline|4751|210154411|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.2|2.3|2.3
20+|0.0|0.0|0.0|Malignant|50|210154411|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.1|2.2|2.1|Benign/Borderline|4520|208297843|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.1|2.2|2.2
20+|0.0|0.0|0.0|Malignant|41|208297843|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|783|207701855|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.3|7.5|7.4|Malignant|15404|207701855|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.3|7.5|7.4
20+|0.4|0.4|0.4|Benign/Borderline|857|210154411|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|7.2|7.4|7.3|Malignant|15469|210154411|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.2|7.5|7.4
20+|0.4|0.5|0.4|Benign/Borderline|888|208297843|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|7.1|7.3|7.2|Malignant|15109|208297843|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.1|7.4|7.3
20+|3.1|3.3|3.2|Benign/Borderline|6631|207701855|Male and Female|Tumors of Sellar Region|2004|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|42|207701855|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.3|3.4|3.4|Benign/Borderline|7077|210154411|Male and Female|Tumors of Sellar Region|2005|3.3|3.4|3.4
20+|0.0|0.0|0.0|Malignant|34|210154411|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|7262|208297843|Male and Female|Tumors of Sellar Region|2006|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|20|208297843|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|8.5|8.7|8.6|Benign/Borderline|17912|207701855|Male and Female|Tumors of the Meninges|2004|8.5|8.8|8.6
20+|0.2|0.3|0.2|Malignant|494|207701855|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|8.9|9.1|9.0|Benign/Borderline|19094|210154411|Male and Female|Tumors of the Meninges|2005|9.0|9.2|9.1
20+|0.2|0.2|0.2|Malignant|474|210154411|Male and Female|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|8.9|9.1|9.0|Benign/Borderline|19068|208297843|Male and Female|Tumors of the Meninges|2006|9.0|9.3|9.2
20+|0.2|0.2|0.2|Malignant|425|208297843|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|1583|207701855|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.8
20+|0.6|0.6|0.6|Malignant|1288|207701855|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|1718|210154411|Male and Female|Unclassified Tumors|2005|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|1233|210154411|Male and Female|Unclassified Tumors|2005|0.6|0.6|0.6
20+|0.7|0.8|0.8|Benign/Borderline|1636|208297843|Male and Female|Unclassified Tumors|2006|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|1184|208297843|Male and Female|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|143|207701855|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|207701855|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|139|210154411|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|210154411|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|150|208297843|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|208297843|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
